We use cookies to provide the best site experience.
Saqer Alkhadem
Founder
Chairman of the Board
Chief Executive Officer
Chairman of the Board
Chief Executive Officer
Saqer Alkhadem is the founder and CEO of Medlex Holding Company, a multi-sector business group created to unify and scale a growing portfolio of ventures. His career began with independently managing operations in education, digital services, retail, and organizational development. Recognizing the need for centralized strategy and governance, he established MHC to formalize leadership, streamline management, and lay the foundation for long-term expansion.
His leadership philosophy centers on clarity, structure, and continuous learning. Saqer emphasizes direction over authority, building capable teams that move with purpose, discipline, and shared intent.
He holds a Doctor of Medicine (MD) degree, providing a foundation in analytical thinking and high-stakes decision-making. Complementing this are advanced studies in psychology, behavioral leadership, and organizational strategy, along with a degree in Business Administration focused on Human Relations. This intersection of medicine, psychology, and business enables him to lead with both precision and insight.
Under his leadership, MHC operates across key sectors including healthcare, technology, AI, education, real estate, and creative industries. His approach is systems-driven — aligning departments, scaling infrastructure, and building cross-functional teams under a unified corporate vision.
Saqer’s long-term objective is to position MHC as an enduring, globally recognized enterprise defined by clarity, resilience, and structural excellence.
His leadership philosophy centers on clarity, structure, and continuous learning. Saqer emphasizes direction over authority, building capable teams that move with purpose, discipline, and shared intent.
He holds a Doctor of Medicine (MD) degree, providing a foundation in analytical thinking and high-stakes decision-making. Complementing this are advanced studies in psychology, behavioral leadership, and organizational strategy, along with a degree in Business Administration focused on Human Relations. This intersection of medicine, psychology, and business enables him to lead with both precision and insight.
Under his leadership, MHC operates across key sectors including healthcare, technology, AI, education, real estate, and creative industries. His approach is systems-driven — aligning departments, scaling infrastructure, and building cross-functional teams under a unified corporate vision.
Saqer’s long-term objective is to position MHC as an enduring, globally recognized enterprise defined by clarity, resilience, and structural excellence.
C-Suite Leadership
The C-Suite leadership team of Medlex Holding is responsible for setting group-wide direction, overseeing strategic operations, and ensuring alignment across all departments. Each Chief Officer plays a critical role in shaping the company's expansion, internal governance, and multi-sector performance.
Alexander Suleikin
Chief Technology Officer
Chief AI Officer
Chief AI Officer
Alexander Suleikin leads the technological and AI strategy at MHC, overseeing innovation across digital infrastructure, artificial intelligence, and enterprise data systems. With over a decade of experience in architecting and implementing advanced IT solutions — including big data platforms, data lakes, and digital ecosystems — he plays a central role in driving the group's digital transformation.
An accomplished academic and researcher, Dr. Suleikin holds a PhD in Technical Sciences and serves as an associate professor in Big Data Architecture. He has authored over 34 peer-reviewed publications indexed in WoS and Scopus, including Q1-ranked journals. His expertise spans more than six technological domains, demonstrating deep cross-sectoral insight and applied innovation.
His academic background includes specialized training in automation and digital production architecture. He has been recognized with multiple scholarships and distinctions in scientific and technological competitions.
An accomplished academic and researcher, Dr. Suleikin holds a PhD in Technical Sciences and serves as an associate professor in Big Data Architecture. He has authored over 34 peer-reviewed publications indexed in WoS and Scopus, including Q1-ranked journals. His expertise spans more than six technological domains, demonstrating deep cross-sectoral insight and applied innovation.
His academic background includes specialized training in automation and digital production architecture. He has been recognized with multiple scholarships and distinctions in scientific and technological competitions.
Ibrahim H.
Chief Financial Officer
Ibrahim is the Chief Financial Officer of MHC, responsible for defining the group’s financial vision, managing strategic budgeting, and overseeing capital structure across all sectors.
His leadership ensures long-term financial sustainability, rigorous risk management, and precise alignment between growth strategies and fiscal performance.
He holds specialized certifications in financial and administrative marketing, along with qualifications in financial technology (FinTech) and digital finance. This multidisciplinary background enables him to integrate traditional financial practices with advanced digital tools — positioning MHC at the forefront of modern financial operations.
As a key member of the executive leadership, Ibrahim shapes major investment decisions, develops robust financial models, and plays a central role in driving the holding’s expansion across diverse industries.
His leadership ensures long-term financial sustainability, rigorous risk management, and precise alignment between growth strategies and fiscal performance.
He holds specialized certifications in financial and administrative marketing, along with qualifications in financial technology (FinTech) and digital finance. This multidisciplinary background enables him to integrate traditional financial practices with advanced digital tools — positioning MHC at the forefront of modern financial operations.
As a key member of the executive leadership, Ibrahim shapes major investment decisions, develops robust financial models, and plays a central role in driving the holding’s expansion across diverse industries.
Ali Alhaddad
Chief Foreign Affairs Officer – Medical Affairs & Development
Ali is the Head of China Affairs at MHC, where he directs the company’s strategic initiatives, institutional partnerships, and high-level engagements across the Chinese market.
He holds a Doctor of Medicine (MD) degree from the People’s Republic of China, complemented by specialized training in Medical Business Administration, Internal Medicine, and Public Relations. His long-standing professional and academic presence in China has equipped him with an in-depth understanding of its healthcare infrastructure, regulatory environment, and business protocols.
Leveraging this background, Ali leads MHC’s positioning and outreach in China — shaping negotiations, facilitating cross-border collaborations, and ensuring that the group’s operations align with the dynamics of one of the world’s most influential economies. His leadership plays a central role in building Medlex’s institutional credibility and strategic presence within the region.
He holds a Doctor of Medicine (MD) degree from the People’s Republic of China, complemented by specialized training in Medical Business Administration, Internal Medicine, and Public Relations. His long-standing professional and academic presence in China has equipped him with an in-depth understanding of its healthcare infrastructure, regulatory environment, and business protocols.
Leveraging this background, Ali leads MHC’s positioning and outreach in China — shaping negotiations, facilitating cross-border collaborations, and ensuring that the group’s operations align with the dynamics of one of the world’s most influential economies. His leadership plays a central role in building Medlex’s institutional credibility and strategic presence within the region.
Julia Isaeva
Chief Operational Officer
Julia Isaeva is Chief Operational Officer at MHC, responsible for the group’s internal systems, cross-functional execution, and organizational efficiency. She holds an MBA in strategic management and brings experience in business operations, corporate structure, and international market development.
Her expertise lies in turning complex strategies into clear, scalable processes. She has led commercial planning, operational design, and internal restructuring projects across industries — building systems that support sustainable growth, performance accountability, and resource alignment. Julia has also contributed to strategic brand development, market localization, and organizational communication, equipping her with a broad and integrated business perspective.
At Medlex, she ensures that vision is matched with structure — designing operational frameworks, optimizing internal collaboration, and creating the conditions necessary for long-term, multi-sector expansion.
Her expertise lies in turning complex strategies into clear, scalable processes. She has led commercial planning, operational design, and internal restructuring projects across industries — building systems that support sustainable growth, performance accountability, and resource alignment. Julia has also contributed to strategic brand development, market localization, and organizational communication, equipping her with a broad and integrated business perspective.
At Medlex, she ensures that vision is matched with structure — designing operational frameworks, optimizing internal collaboration, and creating the conditions necessary for long-term, multi-sector expansion.
Executive Directors
Executive Directors lead the primary divisions of Medlex Holding Company, managing daily operations, performance, and strategic execution within their sectors. They are accountable for turning vision into action at the departmental level.
- Angelina EgorovaExecutive Director – IT DepartmentOversees all internal technical operations, infrastructure management, and software development across the holding. Ensures system efficiency, cybersecurity, and scalable tech architecture for all Medlex ventures.
- Anastasia SheldyakovaExecutive Director – Medlex AcademyLeads the education division, overseeing the development of all academic programs, institutional partnerships, and student-focused initiatives across sub-academies (IT & AI, Aesthetics, Languages).
- Aya AboudExecutive Director – Medlex FashionManages all fashion ventures under the holding, from product development and brand direction to logistics, retail strategy, and sub-brand creation (e.g., kidswear, medical apparel).
- Oksana SokovenkoExecutive Director – Corporate Risk & InsuranceOversees corporate risk, insurance strategy, and compliance policies across the holding, ensuring operational protection, liability control, and alignment with regulatory standards.
© 2020-2025 Medlex Holding Company
Commercial Registry 2251505419
Aligned with the objectives of Saudi Vision 2030
Commercial Registry 2251505419
Aligned with the objectives of Saudi Vision 2030